22-19880654-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_006440.5(TXNRD2):​c.1150G>A​(p.Gly384Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00619 in 1,613,390 control chromosomes in the GnomAD database, including 86 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G384R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0070 ( 7 hom., cov: 33)
Exomes 𝑓: 0.0061 ( 79 hom. )

Consequence

TXNRD2
NM_006440.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 3.33

Publications

7 publications found
Variant links:
Genes affected
TXNRD2 (HGNC:18155): (thioredoxin reductase 2) The protein encoded by this gene belongs to the pyridine nucleotide-disulfide oxidoreductase family, and is a member of the thioredoxin (Trx) system. Three thioredoxin reductase (TrxR) isozymes are found in mammals. TrxRs are selenocysteine-containing flavoenzymes, which reduce thioredoxins, as well as other substrates, and play a key role in redox homoeostasis. This gene encodes a mitochondrial form important for scavenging reactive oxygen species in mitochondria. It functions as a homodimer containing FAD, and selenocysteine (Sec) at the active site. Sec is encoded by UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternatively spliced transcript variants encoding different isoforms, including a few localized in the cytosol and some lacking the C-terminal Sec residue, have been found for this gene. [provided by RefSeq, Jun 2017]
TXNRD2 Gene-Disease associations (from GenCC):
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial glucocorticoid deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • glucocorticoid deficiency 5
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0055096447).
BP6
Variant 22-19880654-C-T is Benign according to our data. Variant chr22-19880654-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 263784.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 7 AD,AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TXNRD2NM_006440.5 linkc.1150G>A p.Gly384Ser missense_variant Exon 13 of 18 ENST00000400521.7 NP_006431.2 Q9NNW7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TXNRD2ENST00000400521.7 linkc.1150G>A p.Gly384Ser missense_variant Exon 13 of 18 1 NM_006440.5 ENSP00000383365.1 Q9NNW7-1

Frequencies

GnomAD3 genomes
AF:
0.00705
AC:
1073
AN:
152208
Hom.:
7
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.00687
Gnomad ASJ
AF:
0.0444
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0205
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00795
Gnomad OTH
AF:
0.00717
GnomAD2 exomes
AF:
0.00760
AC:
1891
AN:
248654
AF XY:
0.00709
show subpopulations
Gnomad AFR exome
AF:
0.000390
Gnomad AMR exome
AF:
0.00246
Gnomad ASJ exome
AF:
0.0381
Gnomad EAS exome
AF:
0.0000557
Gnomad FIN exome
AF:
0.0186
Gnomad NFE exome
AF:
0.00843
Gnomad OTH exome
AF:
0.00845
GnomAD4 exome
AF:
0.00610
AC:
8906
AN:
1461064
Hom.:
79
Cov.:
31
AF XY:
0.00599
AC XY:
4352
AN XY:
726844
show subpopulations
African (AFR)
AF:
0.000358
AC:
12
AN:
33478
American (AMR)
AF:
0.00282
AC:
126
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0425
AC:
1110
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000359
AC:
31
AN:
86254
European-Finnish (FIN)
AF:
0.0185
AC:
975
AN:
52658
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5768
European-Non Finnish (NFE)
AF:
0.00560
AC:
6228
AN:
1111960
Other (OTH)
AF:
0.00689
AC:
416
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
461
923
1384
1846
2307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
196
392
588
784
980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00704
AC:
1073
AN:
152326
Hom.:
7
Cov.:
33
AF XY:
0.00749
AC XY:
558
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000553
AC:
23
AN:
41576
American (AMR)
AF:
0.00686
AC:
105
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0444
AC:
154
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.0205
AC:
218
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00795
AC:
541
AN:
68030
Other (OTH)
AF:
0.00710
AC:
15
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
57
113
170
226
283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00756
Hom.:
26
Bravo
AF:
0.00547
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000724
AC:
3
ESP6500EA
AF:
0.00570
AC:
48
ExAC
AF:
0.00764
AC:
924
Asia WGS
AF:
0.000866
AC:
4
AN:
3478
EpiCase
AF:
0.00682
EpiControl
AF:
0.00670

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TXNRD2: BP4, BS2 -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jun 26, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Primary dilated cardiomyopathy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
May 15, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
17
DANN
Benign
0.97
DEOGEN2
Benign
0.33
.;.;.;.;.;T;.
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.35
FATHMM_MKL
Benign
0.70
D
LIST_S2
Benign
0.83
.;T;.;.;.;T;.
MetaRNN
Benign
0.0055
T;T;T;T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.9
.;.;.;.;.;L;.
PhyloP100
3.3
PrimateAI
Benign
0.37
T
PROVEAN
Uncertain
-3.0
D;.;.;D;D;D;.
REVEL
Benign
0.18
Sift
Benign
0.12
T;.;.;T;T;T;.
Sift4G
Benign
0.17
T;T;T;T;T;T;T
Polyphen
0.37
.;.;.;.;.;B;.
Vest4
0.34
MVP
0.56
MPC
0.21
ClinPred
0.014
T
GERP RS
4.3
Varity_R
0.080
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs192869629; hg19: chr22-19868177; API